Premium
Quantitation of SAR97276 in mouse tissues by rapid resolution liquid chromatography‐mass spectrometry
Author(s) -
Margout Delphine,
Wein Sharon,
Gandon Hermine,
Gattacceca Florence,
Vial Henri J.,
Bressolle Françoise M. M.
Publication year - 2009
Publication title -
journal of separation science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.72
H-Index - 102
eISSN - 1615-9314
pISSN - 1615-9306
DOI - 10.1002/jssc.200900059
Subject(s) - chromatography , mass spectrometry , chemistry , resolution (logic) , liquid chromatography–mass spectrometry , high performance liquid chromatography , high resolution , mass spectrometry imaging , remote sensing , geology , artificial intelligence , computer science
1,12‐Bis[5‐(2‐hydroxyethyl)‐4‐methyl‐1,3‐thiazol‐3‐ium]dodecane dibromide (SAR97276, T3) is a new antimalarial drug, which is currently being evaluated in clinical trials for severe malaria. Drug accumulation inside the parasite and a dual mechanism of action are a major strength of this compound, as it could help delay the development of resistance. The purpose of this article was to develop a rapid resolution LC‐MS method for quantifying SAR97276 in mouse tissues. The LC system consisted of Zorbax Eclipse XDB C8 (1.8 μm, 50×4.6 mm, 60°C) column. Elution with a gradient mobile phase consisting of ACN–trimethylamine‐formate buffer (pH 3) at a flow rate of 1 mL/min yielded sharp, utmost‐resolved peaks within 2 min. Tissue samples were powdered under liquid nitrogen. After protein precipitation with citric acid, SPE using WCX cartridges was used for sample preparation. There was no influence of the matrix on the detection of either SAR97276 or the IS. Assay precision was <13% and accuracy was 90–107%. The lower LOQs were 3.3 μg/kg in brain and 33 μg/kg in liver and heart. This newly developed method was used to study the tissue distribution of SAR97276 in mouse as part of the ongoing development of SAR97276.